Mylan Makes Offer to Buy Swedish Drugmaker Meda for 92% Premium
They are so determined to make themselves too big to acquire that the will overpay for acquisitions. The irony is that the TEVA offer was almost 90% above where MYL is trading now. Management has no respect or concern for shareholders, and will pretty much #$%$ all over them. That is why the stock is down.